Accelerate your CDMO or DTC pipeline. Map the exact physiochemical constraints, bioavailability synergies, and optimal delivery mechanisms for Eicosapentaenoic Acid.
Eicosapentaenoic acid is a long-chain omega-3 polyunsaturated fatty acid that functions as a competitive substrate for cyclooxygenase and lipoxygenase enzymes to attenuate pro-inflammatory eicosanoid synthesis and promote cardiovascular and cognitive health.
446284
302.5 g/mol
5.6
(5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoic acid
Every active compound behaves uniquely based on the physical matrix it is suspended in. Below are the known physical chemistry challenges for Eicosapentaenoic Acid across standard consumer modalities.
The high susceptibility of EPA to oxidative rancidity requires nitrogen-flushed softgel encapsulation rather than standard dry powder hard-shell capsules to maintain chemical stability.
Incorporating high-load EPA oils into pectin matrices often leads to lipid leaching and significant organoleptic challenges due to the characteristic fishy odor profile.
The high therapeutic dosage requirements and hydrophobic nature of EPA exceed the payload capacity and structural integrity of thin-film polymer matrices.
Ready to launch a product featuring Eicosapentaenoic Acid? Skip months of expensive wet-lab iterations. Generate a manufacturer-ready formulation in hours, instantly screened for physical incompatibilities and global regulatory compliance.
Build Science-Backed FormulationNeed absolute proof that your Eicosapentaenoic Acid extract actually absorbs? Stop blindly combining generic powders. Run a physics-based PBPK simulation to mathematically engineer peak clinical efficacy and targeted plasma concentrations.
Simulate BioavailabilityIs your Eicosapentaenoic Acid payload degrading in the capsule before the expiration date? Stop waiting for costly bench testing. Run an accelerated digital twin to precisely model oxidation pathways and pH shifts before finalizing a manufacturing run.
Model Active Degradation